Summary

Overview
Global Pharmaceutical Cartridges Market reached US$ XX million in 2022 and is expected to reach US$ XX million by 2030, growing at a CAGR of XX% during the forecast period 2023-2030.
Pharmaceutical cartridges are glass containers of cylindrical shape, suitable for liquid or solid pharmaceutical dosage forms. Cartridges are generally designed for a specific apparatus such as pre-filled syringes and autoinjectors.
Insulin , dental anesthesia and other emergency drugs for allergies can be placed in cartridges. They offer reduced drug-container interaction, efficient container processing, high device compatibility and reliable point-of-use performance.
Market Dynamics: Drivers & Restraints
Increase in investments in research and development
The increase in the research and development, increase in technological advancements in drug delivery devices and rise in the chronic diseases is expected to drive the market growth. For instance, in May 2023, Cepheid opened their first manufacturing unit in India in Bengaluru. The 77,000 square-foot facility manufactures the company’s leading Xpert tuberculosis testing cartridges for India and other countries.
Additionally, 22 September 2022, the SCHOTT has deigned double-digit million Euro investment significantly to increase the production capacities for pharmaceutical cartridges in Hungary and China.
Moreover, SCHOTT invested double-digit million Euro in ready-to-use cartridge production. The investment is designed to increase the production capacity of ready-to-use cartridges in St. Gallen, Switzerland.The expansion is designed to break ground with glass-to-glass contact-free cartridge processing.
Thus, increase in the investments by the companies in order to develop the advanced cartridges is expected to drive the market growth.
Restraint
High cost of development
High manufacturing and developmental costs of the pharmaceutical cartridges can reduce the production and the high cost of the drugs that are to be given to the chronic diseased patients is expected to hinder the market growth. This can reduce the accessibility for the patients in developing and under developed countries.
Segment Analysis
The global pharmaceutical cartridges market is segmented based on type, material, application, end-user and region.
Dual chamber cartridges segment accounted for 57.6% of the market share
The two chambers of the dual chambered catridges are separated by a plunger and a system allows the two substances to be mixed or reconstituted right before administration. Dual chamber cartridges segment is expected to hold the dominant segment in the market share due to its dose accuracy and efficiency, patient conviniency.
They provide high stability and convenience to patients and doctors, thus significantly improving product quality, patient compliance. double chamber cartridges provide an interesting packaging option they contain two drug components in two consecutive chambers that are separated by a plunger. Thus, the above features are expected to hold the segment in the dominant position.
Geographical Analysis
North America is expected to hold a significant position in the global pharmaceutical cartridges market share
North America is expected to hold a dominant position in the market growth owing to the increase in the pharmaceutical production, increasing prevalence of chronic diseases and increasing demand for the drugs etc. Advanced healthcare infrastructure in the region is also a factor that drives the market growth in the region.
The increase in chronic conditions such as diabetes, cancer among others are increasing the demand for cartridges in the region. The increased launches of dual chambered cartridges and increased investments in research adn development are also factors driving the market growth. For instance, according to the report by the CDC, it is estimated that every year approximately 1,958,310 new cancer cases are reported.
COVID-19 Impact Analysis
COVID-19 had impacted the market growth positively. There is an increase in the growth of the market dure to the rapid development and deployment of COVID-19 vaccines and treatments have increased the demand for the cartridges. The increased government funding and also the increased demand for the healthcare infrastructure for the treatment of COVID-19 has driven the market growth.
Market Segmentation
By Type
• Dual Chamber Cartridges
• Large Volume Cartridges
By Material
• Glass
o Type I
o Type II
o Type III
o Type IV
o Type V
• Plastic
o Polyethylene Terephthalate (PET)
o High-Density Polyethylene (HDPE)
o Other
• Rubber
By Application
• Ophthalmology
• Respiratory
• Neurology
• Immunology
• Cardiology
• Diabetes
• Dental
• Others
By End-User
• Pharmaceutical Industries
• Biotechnology Companies
• Homecare
• Hospitals
• Others
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o UK
o France
o Italy
o Spain
o Rest of Europe
• South America
o Brazil
o Argentina
o Rest of South America
• Asia-Pacific
o China
o India
o Japan
o Australia
o Rest of Asia-Pacific
• Middle East and Africa
Competitive Landscape
The leading companies with a significant market share include Nipro Corporation, Gerresheimer AG, Stevanato Group, Schott AG., Shandong Province Medicinal Glass Co., Ltd., Wellona Pharma, Livealth Biopharma Pvt Ltd., West Pharmaceutical Services, Inc., Zoic Biotech Private Limited and SiNi Pharma Pvt Ltd among others.
Why Purchase the Report?
• To visualize the global pharmaceutical cartridges market segmentation based on type, material, application, end-user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of pharmaceutical cartridges market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.
The global pharmaceutical cartridges market report would provide approximately 69 tables, 73 figures, and 180 Pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

ページTOPに戻る

Table of Contents

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Type
3.2. Snippet by Material
3.3. Snippet by Application
3.4. Snippet by End-User
3.5. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Increase in investments in research and development
4.1.1.2. XX
4.1.2. Restraints
4.1.2.1. High cost of the development
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Epidemiology Statistics
5.4. Pricing Analysis
5.5. Regulatory Analysis
5.6. Russia-Ukraine War Impact Analysis
5.7. DMI Opinion
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
7.1.2. Market Attractiveness Index, By Type
7.2. Dual Chamber Cartridges
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Large Volume Cartridges
8. By Material
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
8.1.2. Market Attractiveness Index, By Material
8.2. Glass Source
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.2.3. Type I
8.2.4. Type II
8.2.5. Type III
8.2.6. Type IV
8.2.7. Type V
8.3. Plastic
8.3.1. Polyethylene Terephthalate (PET)
8.3.2. High-Density Polyethylene (HDPE)
8.3.3. Others
8.4. Rubber
9. By Application
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.1.2. Market Attractiveness Index, By Application
9.2. Diabetes
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Dental
9.4. Ophthalmology
9.5. Respiratory
9.6. Neurology
9.7. Immunology
9.8. Cardiology
9.9. Others
10. By End-User
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10.1.2. Market Attractiveness Index, By End-User
10.2. Pharmaceutical Industries
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Biotechnology Companies
10.4. Homecare
10.5. Hospitals
10.6. Others
11. By Region
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
11.1.2. Market Attractiveness Index, By Region
11.2. North America
11.2.1. Introduction
11.2.2. Key Region-Specific Dynamics
11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.2.7.1. U.S.
11.2.7.2. Canada
11.2.7.3. Mexico
11.3. Europe
11.3.1. Introduction
11.3.2. Key Region-Specific Dynamics
11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.3.7.1. Germany
11.3.7.2. UK
11.3.7.3. France
11.3.7.4. Italy
11.3.7.5. Spain
11.3.7.6. Rest of Europe
11.4. South America
11.4.1. Introduction
11.4.2. Key Region-Specific Dynamics
11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.4.7.1. Brazil
11.4.7.2. Argentina
11.4.7.3. Rest of South America
11.5. Asia-Pacific
11.5.1. Introduction
11.5.2. Key Region-Specific Dynamics
11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.5.7.1. China
11.5.7.2. India
11.5.7.3. Japan
11.5.7.4. Australia
11.5.7.5. Rest of Asia-Pacific
11.6. Middle East and Africa
11.6.1. Introduction
11.6.2. Key Region-Specific Dynamics
11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
12. Competitive Landscape
12.1. Competitive Scenario
12.2. Market Positioning/Share Analysis
12.3. Mergers and Acquisitions Analysis
13. Company Profiles
13.1. Nipro Corporation *
13.1.1. Company Overview
13.1.2. Product Portfolio and Description
13.1.3. Financial Overview
13.1.4. Key Developments
13.2. Gerresheimer AG
13.3. Stevanato Group
13.4. Schott AG.
13.5. Shandong Province Medicinal Glass Co., Ltd.
13.6. Wellona Pharma
13.7. Livealth Biopharma Pvt Ltd.
13.8. West Pharmaceutical Services, Inc.
13.9. Zoic Biotech Private Limited
13.10. SiNi Pharma Pvt Ltd
LIST NOT EXHAUSTIVE
14. Appendix
14.1. About Us and Services
14.2. Contact Us